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Abstract
Background:  The full-length mammalian homologs of groucho, Tle1, 2, 3, and 4, act as
transcriptional corepressors and are recruited by transcription factors containing an eh1 or
WRPW/Y domain. Many transcription factors critical to pancreas development contain a Gro/TLE
interaction domain and several have been shown to require Gro/TLE interactions for proper
function during neuronal development. However, a detailed analysis of the expression patterns of
the Gro/TLE proteins in pancreas development has not been performed. Moreover, little is known
about the ability of Gro/TLE proteins to interact with transcription factors in the pancreas.
Results: We describe the expression of Gro/TLE family members, and of 34 different transcription
factors that contain a Gro/TLE interaction motif, in the pancreas utilizing nine SAGE libraries
created from the developing and adult pancreas, as well as the GenePaint database. Next, we show
the dynamic expression of Tle1, 2, 3, 4, 5 and 6 during pancreas development by qRT-PCR. To
further define the cell-type specificity of the expression of these proteins we use
immunofluorescence to co-localize them with Pdx1 at embryonic day 12.5 (E12.5), Ngn3 at E14.5,
Pdx1, Nkx2-2, Insulin, Glucagon, Pancreatic polypeptide and Somatostatin at E18.5, as well as
Insulin and Glucagon in the adult. We then show that Tle2 can interact with Nkx2-2, Hes1, Arx,
and Nkx6-1 which are all critical factors in pancreas development. Finally, we demonstrate that
Tle2 modulates the repressive abilities of Arx in a β-cell line.
Conclusion: Although Tle1, 2, 3, and 4 show overlapping expression in pancreatic progenitors and
in the adult islet, the expression of these factors is restricted to different cell types during
endocrine cell maturation. Of note, Tle2 and Tle3 are co-expressed with Gro/TLE interaction
domain containing transcription factors that are essential for endocrine pancreas development. We
further demonstrate that Tle2 can interact with several of these factors and that Tle2 modulate
Arx's repressive activity. Taken together our studies suggest that Gro/TLE proteins play a role in
the repression of target genes during endocrine cell specification.
Background
Many of the transcription factors important in pancreas
development are, or are thought to act as, repressors of tar-
get genes. For example, Nkx2-2 acts as a transcriptional
repressor in the developing neural tube [1,2] and
represses ghrelin cell specification during pancreas devel-
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opment [3]. Pax4 represses the α-cell transcription factor
Arx, which in turn represses Pax4 expression [4]. During
pancreas development Nkx6-1 acts as a context dependent
transcriptional activator or repressor, activating its own
transcription while more broadly repressing gene expres-
sion [5,6]. Nkx6-2 is a repressor of Dbx1 in neuronal
development [7]. In each of these cases, both in the pan-
creas and in neuronal development, transcription factor
mediated repression of target genes requires the recruit-
ment of cofactors. For many of these transcription factors
homologs of Groucho, called the Groucho/Transducin-
like enhancer of split (Gro/TLE) family, fulfill this role
[7,8].
In Drosophila groucho (Gro) acts as a master repressor [9]
and regulates transcriptional repression through interac-
tions with Hairy, Hairy related, and Runt family proteins
via a WRPW/Y motif, as well as with Dorsal, Engrailed,
and Tcf family proteins via an unrelated eh1 (FxIxxIL)
motif [10]. Evidence suggests that Gro recruits histone
deacetylases (HDACs) that modify the local chromo-
somal state, silencing gene transcription. There are at least
six mouse homologs of Gro (Tle1-6), which all have direct
human orthologs. Tle1, 2, 3, 4, and 6 are full-length GRO
subfamily members containing a highly conserved WD-
repeat domain at their carboxy termini and a glutamine
rich (Q) domain at their amino terminal end. Linking
these domains is a weakly conserved central region. Tle5
(AES), that lacks much of the central region and the WD-
repeat domain, acts as a dominant negative repressor of
GRO subfamily members [9-12].
It has been reported that Tle1 and Tle3 have non-overlap-
ping expression patterns in the brain and spinal cord,
while  Tle1,  2, and 4  were shown to be differentially
expressed in in vitro models of neural and chondrocytic
determination [13,14]. Later studies showed that Tle1-4
have unique but overlapping expression patterns, with the
overlaps occurring in putative precursor populations [15].
These results imply that each member of the Gro/TLE fam-
ily has unique functions in specific cell types, despite the
fact they may have similar promiscuous binding affinities
for numerous WRPW/Y and eh1 motif containing pro-
teins, and possibly redundant functions in progenitor cell
types.
Numerous studies have begun to dissect the roles of the
Gro/TLE family members in various developmental sys-
tems. To date, Gro/TLE mediated repression has been
implicated in pituitary and kidney organogenesis, hemat-
opoiesis, and development of both bone and the eye [16-
22]. These studies have revealed a number of pathways
and transcriptional repressors utilizing Gro/TLE proteins.
For example, all Tcf HMG box transcription factors inter-
act with Tle1, 2, 3, and 4 and repress transactivation in a
β-catenin -Tcf reporter gene assay, suggesting a role for the
Gro/TLE proteins in Wnt signaling [23]. In addition,
Foxa2 (HNF3β) has been shown to interact with Tle1 in
Hela and HepG2 cells [24]. The majority of work, how-
ever, has focused on understanding the function of the
mammalian Gro/TLE proteins in neuronal development.
Notch signaling acts to restrict the neural potential of pro-
genitors by antagonizing expression of pro-neural genes.
Both Tle1 and Tle2 interact directly with Hes1 and are
vital to it's repressive abilities [25-27]. Tle1 also interacts
with BF-1 (Foxg1), a regulator of neuronal differentiation
[28], mediating the interaction between BF-1 and Hes1
[28]. Several homeodomain transcription factors (i.e.
Nkx6-1, Nkx6-2, and Nkx2-2) important in pancreas
development are also essential to patterning neuronal
specification in the ventral neural tube and interact with
Gro/TLE proteins [8,29,30]. A cross-repressive model
whereby these transcription factors repress genes involved
in the specification of opposing cell types has been pro-
posed [7]. The Gro/TLE family members are a vital com-
ponent of this model and ectopic expression of Tle5, a
dominant negative inhibitor of Gro/TLE mediated repres-
sion, perturbs neural tube patterning by extending the
expression domains of both Nkx2-2 and Nkx6-1 [8].
In this work we describe the expression of Gro/TLE family
members utilizing nine SAGE libraries created from the
developing and adult pancreas. Additionally we identify,
and assess the expression of, 34 different transcription fac-
tors that contain a Gro/TLE interaction motif in these
libraries, and further demonstrate that at least 13 of these
are expressed in the endocrine lineage. We then show the
dynamic expression of Tle1 through 6 during pancreas
development by qRT-PCR. The cell-type specificity of
Tle1, 2, 3, and 4 expression was assessed using IHC to co-
localize each with Pdx1 at E12.5, Ngn3 at E14.5, Pdx1,
Nkx2-2, Insulin, Glucagon, Pancreatic polypeptide and
Somatostatin at E18.5, and Insulin and Glucagon in the
adult. We then focus on Tle2, as it was expressed widely in
endocrine pancreas development, and show that it can
interact with Nkx2-2, Nkx6-1, Hes1 and Arx which are all
essential in proper endocrine pancreas development.
Finally, we demonstrate that Tle2 can modulate the
repressive abilities of Arx and that this modulation is
dependent upon Arx's Gro/TLE interaction domain.
Results
Identification of Gro/TLE proteins and putative Gro/TLE 
interacting proteins in the developing pancreas
We first assessed the expression of the Gro/TLE family
members in nine Serial Analysis of Gene Expression
(SAGE) libraries generated from the developing and adult
pancreas [31,32]. This data revealed the differential
expression of Tle1 through Tle6, with high levels of both
Tle5 and Tle6, at various stages of pancreas developmentBMC Developmental Biology 2008, 8:81 http://www.biomedcentral.com/1471-213X/8/81
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(Table 1). No tags unambiguously map to Tle4 so it could
not be assessed. Since the Gro/TLE proteins interact with
transcription factors containing an eh1 or WRPW/Y
domain we assessed the expression of the 34 factors
present in our pancreas SAGE libraries. Included in this
group are several factors essential for proper endocrine
cell specification and maturation such as Hes1, Foxa2,
Nkx2-2, and Pou3f4 (Brn4) (Table 1). Arx  and Nkx6-1,
which are essential to proper α- and β-cell development
respectively, and contain an eh1 domain, could not be
detected as Arx does not produce an unambiguous tag
while Nkx6-1 does not contain a NlaIII site and thus does
not produce a SAGE tag.
We then used the GenePaint  http://www.genepaint.org
database to assess the staining patterns of these genes in
the E14.5 pancreas. Tle 2 and  3  both showed modest
staining throughout the epithelium and mesenchyme,
while Tle1 staining was found predominantly in the mes-
enchyme (Figure 1A and Table 2). Expression of Tle4
could not be detected at this time point in the pancreas.
Tle5  and  6  on the other hand showed strong staining
throughout the pancreas epithelium. Informative stain
was obtained for 22 of the 34 transcription factors con-
taining an eh1 or WRPW/Y domain detected in our SAGE
libraries and 11 of these showed stain in the pancreas (Fig-
ure 1B and Table 2). The remaining 11 factors for which
informative staining was produced but no stain was seen
in the pancreas typically showed counts only in the Pdx1
GFP+ libraries or the E12.5 Ngn3 GFP-, including Foxa1,
Foxc1, Pax1, Pax3, and Tbx2, or in libraries representing
later developmental stages, including Foxd3,  Nkx2-5,
Tbx20, and Tlx1. Data from the literature also provided
evidence of the expression of an additional four of these
factors, including Hes1 [33], HlxB9 [34], Nkx6-1 [35], and
Nkx6-2 [36], which are not in the GenePaint  database.
Thus, in addition to our SAGE data, there is independent
evidence demonstrating the expression of thirteen differ-
ent eh1 or WRPW/Y transcription factors (Arx,  Foxa2,
Foxa3, Hes1, Hes6, Hhex, HlxB9, Nkx2-2, Nkx6-1, Nkx6-2,
Pou3f4, Tcf1, and Tcf2), many of which have well estab-
lished roles in endocrine pancreas development.
qRT-PCR analysis of Gro/TLE genes in pancreas 
development
To determine the overall expression profiles of these genes
in pancreas development we assessed their expression by
qRT-PCR from E11.5 through to adult islets (Figure 2).
The expression profiles of Tle1 and Tle2 were highly simi-
lar, and transcripts for both generally became more abun-
dant as development progressed with peak expression in
the adult islets. Tle3 expression dropped from E11.5 to
E15.5 and was increased again at E18.5 and in adult islets.
Tle4 expression also dropped at E13.5 and stayed low at
the remaining time points analyzed, although levels in the
adult islets were higher than those found at E13.5 to
E18.5. Tle5 expression increased in abundance with devel-
opment and highest levels were found in adult islets. Tle6
expression was almost inverted compared with the Tle3
and Tle4 profiles, with peak expression at E18.5 and rela-
tively low levels in the islet and E11.5 samples.
Expression of Gro/TLE proteins at the start of the 
secondary transition
To determine the cell type specificities of Tle1-4 we first
analyzed their co-expression with Pdx1, whose expression
marks the first appearance of cells capable of giving rise to
the endocrine and exocrine pancreas as well as the duode-
num [37,38] (Figure 3 and Table 3). It was not possible to
obtain Tle5 or Tle6 protein expression data since there are
currently no suitable antibodies for these proteins. At this
time point (E12.5) Tle1, 2, and 3 were expressed through-
out the pancreatic epithelium and all Pdx1 positive cells
were also positive for these three Gro/TLE proteins. A few
Tle2 and Tle3 positive cells in the pancreatic epithelium
were Pdx1 negative. These cells likely correspond to cells
that have undergone early differentiation into glucagon
positive cells. Tle4 was absent from the pancreatic epithe-
lium and did not co-localize with Pdx1. All four of these
Gro/TLE proteins were expressed in the mesenchyme sur-
rounding the developing pancreas, with Tle1 and Tle3
expressed in a few such cells, while Tle2 and Tle4 were
widely expressed.
Expression of Gro/TLE proteins at the end of the 
secondary transition
During the secondary transition endocrine progenitors
lose expression of Notch signaling components, such as
Hes1, and begin to express the bHLH factor Ngn3. In neu-
ronal development Tle1 expression is likewise lost during
neural specification of progenitors. To see if a similar
process occurs in the pancreas we co-localized Tle1-4 with
Ngn3 in the E14.5 developing pancreas. Unlike at E12.5
where Tle1-3 were expressed throughout the pancreatic
epithelium these factors clearly showed more restricted
expression at E14.5 (Figure 4 and Table 4). At this time
point Tle1 was absent from the pancreatic epithelium.
Tle2 and Tle3 on the other hand both showed scattered
expression through the epithelium. Also, both Tle2 and
Tle3 co-localized with Ngn3 in a subset of Ngn3 positive
cells. Interestingly, cells that were Ngn3 and Tle2 or Tle3
double positive, cells that were Ngn3 positive and Tle2
and Tle3 negative, and cells that were Ngn3 negative and
Tle2 and Tle3 positive, were found (Figure 5). Tle4 was
again absent from epithelial cells. Tle3 was only found in
a restricted set of mesenchymal cells as observed at E12.5,
while Tle1, 2, and 4 were widely expressed in the mesen-
chyme.B
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Table 1: Counts of unambiguously identified Gro/TLE family members and eh1 or WRPW domain containing transcription factors in nine pancreas SAGE libraries
Tag PositionΦ Accession Symbol Pdx1 GFP+
E10.5
306588
Pdx1 GFP+
E11.5
317716
Ngn3 GFP-
E12.5
308745
Ngn3 GFP+
E12.5
320473
Ngn3 GFP+
E13.5
320473
Ngn3 GFP+
E14.5
301222
Whole
E14.5
98189
Whole
E18.5
81130
Islets
Adult
99968
S
Gro/TLE family members
TGAACAAGC
CTGACAAG
2 NM_011599 Tle1
ATGCAGAGC
GCCACAGA
16 NM_011599 Tle1
AGAGCTGCG
TGCTGTCA
2 NM_019725 Tle2 0 0 1052 0 0 0 0 . 5
GAGAGCAGC
AATGTGGA
1 NM_009389 Tle3 0 0 0000 0 0 1 0 . 0
- - NM_010347 Tle4 - - ---- - - - -
TACTATGAG
ATGTCCTA
1 NM_010347 Aes 003 51 1 7000 0 . 2
GGGTGTGCA
GATCCCGA
1 NM_053254 Tle6 132 12 0 9020 4 . 4
Transcription factors containing an eh1 or WRPW Domain
- - NM_007492* Arx - - ---- - - - 0 . 0 4
GGAGTTTTC
AAGCACTG
1 NM_010132 Emx2 2 1 0000 0 0 0 0 . 0 9
TTAACGACA
AAAAAAAA
1 NM_008259 Foxa1 0 3 0 0 0 0 0 0 0 11.46
GTGAAATCC
AGGTCTCG
1 NM_010446 Foxa2 0 4 01 21 2 8448 4 . 0 8
TAGTTTTAAC
AGAAAAC
2 NM_010446 Foxa2 0 1 0032 0 0 0 3 . 8 5
CTGCTATGC
ACCAAGAT
1 NM_008260 Foxa3 0 0 1131 0 0 0 0 . 0 3
GACTTGTTTT
TAAATGT
4 NM_008592 Foxc1 1 0 0000 0 0 0 0 . 2 8
GCTTTGTAC
AGTAGATG
1 NM_013519 Foxc2 3 0 0000 0 4 0 0 . 0 9
GCCACGCAC
CAGCCCCT
1 NM_010425 Foxd3 0 0 0000 0 0 1 0 . 1 3
CACTGCATTT
GTATATA
1 NM_008235 Hes1 0 1 2 0 1 0 0 2 0 13.61
CCGCTGCGT
GAGGGTAG
1 NM_019479 Hes6 32 3 5 52 13 20 1 0 1 0.04
TTGGCTTCTC
TTCCAGT
1 NM_010420 Hesx1 0 0 0000 0 0 0 0 . 3 2
TATATAGCAT
TACTTCT
2 NM_008245 Hhex 0 1 1141 0 1 0 4 . 6 8
CTAAATTATT
ATTTAGC
1 NM_019944 Hlxb9 0 0 0001 0 0 2 4 . 0 3B
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AGCATTCAG
ATTGCTGA
2 NM_019944 Hlxb9 0 0 0020 0 0 0 0 . 4 7
CTGGTGCTT
CACCAAGG
1 NM_010835 Msx1 10 1 15 0 0 0 0 0 0 68.93
TACACGTTCT
GACAACT
1 NM_010919 Nkx2-2 110 61 4 9012 6 . 9 8
GAACTCAGC
GGAGAAAG
1 NM_008699 Nkx2-3 1 0 1 3100 6 0 0 0 . 0 5
CTGGCCGCC
TTCAAGCC
1 NM_008700 Nkx2-5 0 0 0000 0 2 0 0 . 0 9
CGGGGAGGC
TGTCCCCA
3 NM_008700 Nkx2-5 0 0 1000 0 0 0 -
- - NM_144955* Nkx6-1 - - ---- - - - 1 . 9 5
CCCCGACGC
CAGCCGCC
4 NM_183248 Nkx6-2 2 7 0120 0 0 0 0 . 1 3
GCTGCCTTT
GAATAAAG
1 NM_008780 Pax1 3 0 0000 0 0 0 1 . 9 2
TTCTTAATGA
GGTCAGC
3 NM_008781 Pax3 1 0 0000 0 0 0 0 . 0 2
CCTAAAGAT
TCCGCCGC
1 NM_008900 Pou3f3 3 0 0 0 0 0 0 0 0 54.12
TGCAAGCTG
AAACCGCT
1 NM_008901 Pou3f4 1103 8 3 7000 0 . 0 5
CAGGAGAAA
CCCTGAGA
1 NM_009323 Tbx15 0 0 0001 0 0 0 0 . 3 7
GCAGCAGCG
GCCGCCGC
1 NM_009324 Tbx2 0 0 5000 0 0 0 0 . 7 7
AAACAGGTG
TTAAAAAC
1 NM_020496 Tbx20 0 0 0000 0 1 0 5 . 9 4
ACTGTCTCC
TCGGGCCT
4 NM_009327 Tcf1 0 1 0141 0 1 0 0 . 6 8
TTAAGACAC
ATCTCTGG
1 NM_009330 Tcf2 0 1 0031 0 0 0 0 . 5 4
CCCACCAGG
CCCTCCCC
2 NM_009332 Tcf3 9 2 3110 0 0 0 0 . 6 3
ACCAGGCCT
GGAGTTCT
1 NM_009332 Tcf3 7 1 1120 0 0 0 0 . 2 4
GGACAGATG
TGAAAAGG
5 NM_013685 Tcf4 6 1 5130 3 1 1 0 . 0 5
GTCAGATTTT
TTTTGGA
1 NM_013685 Tcf4 1 1 1 2 3 0 1 1 1 35.34
GGACAGAGA
GACCCAAG
1 NM_021901 Tlx1 0 0 1000 0 0 0 0 . 0 4
Φ Tag position is calculated by assigning the 3' most CATG in the transcript as the position 1 tag and the next 3' most CATG the position 2 tag etc.
*Tags counts are shown as tags per hundred thousand. This indicates the total number of times a given SAGE tag appears in the library per hundred thousand tags and is used to normalize for 
libraries of varying size
 S is the specificity of the tag. Specificity is calculated as described in the materials and methods.
*No unambiguous tags exist for Nkx6-1 or Arx although their expression within the pancreas is well established.
Table 1: Counts of unambiguously identified Gro/TLE family members and eh1 or WRPW domain containing transcription factors in nine pancreas SAGE libraries (Continued)BMC Developmental Biology 2008, 8:81 http://www.biomedcentral.com/1471-213X/8/81
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Expression of Gro/TLE proteins at E18.5, after the 
secondary transition
Beyond being implicated in controlling progenitor cell
maintenance, Gro/TLE proteins also play a role in the
maturation of a wide variety of specialized cell types. As
previously mentioned many of the transcription factors
that play significant roles in proper endocrine cell specifi-
cation and maturation contain a Gro/TLE interaction
domain. To determine which Gro/TLE family members
are co-expressed with, and thus might interact with, these
factors we co-localized the expression of Tle1 through 4
with Pdx1, Nkx2-2, Insulin, Glucagon, Pancreatic
polypeptide, and Somatostatin, which between them
mark the four predominant endocrine cell types in the
pancreas, at E18.5.
Tle1 was found only in a few endocrine cells and its
expression partially over-lapped only with Pdx1, which at
this time point is restricted to β and δ cells. Tle1 expres-
sion was not seen in either Insulin or Glucagon positive
cells. However it was found in cells that stained for the δ
cell marker Somatostatin as well as in cells that stained for
Pancreatic polypeptide (PP) (Figure 6). Tle2 was abun-
dant in endocrine cells and all Pdx1 and Nkx2-2 positive
cells were also Tle2 positive. Tle2 was also found in Insu-
lin, Glucagon, Somatostatin and PP positive cells. Tle3
was nearly as broadly expressed as Tle2 and was found in
all Pdx1 positive cells, and most Nkx2-2 positive cells.
Tle3 was also found in Insulin, Glucagon, and Somatosta-
tin positive cells but not in PP positive cells. Tle4 was
found in rare endocrine cells, none of which expressed
Pdx1 or Nkx2-2. Tle4 was also not found in Insulin, Glu-
cagon, PP, or Somatostatin positive cells (Figure 6). A
summary of these results can be found in Table 5.
Expression of Gro/TLE proteins in the adult
Our qRT-PCR data suggests that the expression of Tle1, 2,
and 3 peaks in the adult islets, while expression of Tle4 is
almost as high as seen at E11.5. To determine if these
genes show cell type specificity of expression within adult
islets we next co-localized them with Insulin and Gluca-
gon. Tle1, 2, 3 and 4 expression was quite broad within
islets cell types, although Tle4 staining was noticeably
weaker. Each of these proteins co-localized with Insulin in
the majority of Insulin positive cells. However, in each
case a number of cells positive only for Insulin were iden-
Expression of Gro/TLE family members and transcription factors with a Gro/TLE interaction domain in the developing pan- creas Figure 1
Expression of Gro/TLE family members and transcription factors with a Gro/TLE interaction domain in the 
developing pancreas. Images of in situ hybridization staining patterns for (A) Gro/TLE family members and (B) transcription 
factors with a Gro/TLE interaction domain on E14.5 whole embryo sagittal sections were obtained from the GenePaint website 
and magnified to show the pancreas (outlined in red).
Nkx2-2
Nkx2-3 Pou3f4 Tcf1 Tcf2 Tcf4
Arx Foxa2 Foxa3 Hes6
A
B
Tle5 Tle1 Tle2 Tle3 Tle4 Tle6BMC Developmental Biology 2008, 8:81 http://www.biomedcentral.com/1471-213X/8/81
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tified (Figure 7). All of the Glucagon positive cells were
also Tle2 and Tle3 positive (Figure 7). The majority of
Glucagon positive cells were also Tle1 and/or Tle4 posi-
tive. Thus clearly Tle1, 2, 3, and 4 are expressed in both of
the major hormone producing cell types in the islet (Table
6). To characterize the Insulin or Glucagon positive Gro/
TLE negative cells further we co-localized the Gro/TLE's
using a pan-TLE antibody with PCNA, a marker of prolif-
erating cells. All PCNA positive cells showed no or very
weak Gro/TLE staining. Several Gro/TLE negative PCNA
negative cells were also identified. We also assessed the co-
localization of Tle1 through 4 with dolichos biflorus
agglutinin (DBA) that marks ductal cells (data not
shown). Only Tle2 and Tle3 were found in DBA positive
cells. In acinar cells expression of all four of the Tle pro-
Table 2: Classification of Gro/TLE family members and eh1 or WRPW domain containing transcription factors into the five expression 
domains in the developing pancreas using the GenePaint database
Symbol GenePaint Id#o Trunk Tip Epithelium Vasculature Mesenchyme Not detected#
Gro/TLE family members
Tle1 MH424 M^
Tle2 MH2206 M M
Tle3 MH392 M M
Tle4 EB1917 Y
Tle5 N/A
Tle6 MH1997 S
Transcription factors containing an eh1 or WRPW Domain
Arx MH740 S
Emx2 N/A
Foxa1 MH864 Y
Foxa2 MH515 M
Foxa3 EH531 M
Foxc1 ES2315 Y
Foxc2 N/A
Foxd3 MH620 Y
Hes1 N/A
Hes6 MH945 M W
Hesx1 N/A
Hhex EB22 W
Hlxb9 N/A
Msx1 N/A
Nkx2-2 EN1299 M
Nkx2-3 EB1495 M
Nkx2-5 MH1017 Y
Nkx6-1 N/A
Nkx6-2 N/A
Pax1 EN1275 Y
Pax3 ES1828 Y
Pou3f3 N/A
Pou3f4 MH930 M
Tbx15 EH1284 Y
Tbx2 EG1241 Y
Tbx20 EG2245 Y
Tcf1 EB1413 W W
Tcf2 MH809 S
Tcf3 MH770 Y
Tcf4 MH934 M
Tlx1 EH430 Y
o The accession number of the gene in the GenePaint database http://www.genepaint.org, N/A indicates that the gene is not present in the database 
or that the sections containing informative stain in the pancreas were not present
^ W indicates weak staining, M indicates moderate staining, and S indicates strong staining
#Not detected indicates that the probe for the gene produced staining in the embryo, suggesting the probe was functional, but no staining was seen 
in the pancreasBMC Developmental Biology 2008, 8:81 http://www.biomedcentral.com/1471-213X/8/81
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teins was found, although Tle4 was present in only a very
few cells.
Interactions between Tle2 and transcription factors 
essential to proper pancreas development
Based on our expression profiling results Tle2 and Tle3 are
the most likely candidates to be functional co-repressors
for critical endocrine cell transcriptional repressors such
as Nkx2-2, Nkx6-1, and others. In support of this, Tle3
interacts with Nkx2-2 in the pancreas [3] and knocking in
a mutant Nkx2-2 containing the activation domain but
not the Gro/TLE interaction domain produces a pheno-
type similar to the Nkx2-2 knock out [3] demonstrating
that this domain is critical to proper Nkx2-2 function.
However, the transcription factors that Tle2 interacts with
in the developing pancreas are not known. Thus to deter-
mine if Tle2 interacts with transcription factors critical to
key stages in pancreas development we used co-immuno-
precipitation in the Min6 β-cell line. We first attempted to
determine if Tle2, like Tle3, can interact with Nkx2-2 that
is essential for the proper specification and maturation of
α, β, and PP cells. Anti-Nkx2-2 blots of material immuno-
precipitated using an anti-Tle2 antibody produced an ~30
kDa band that was not seen in controls (rabbit IgG used
in immunoprecipitation) but was found in western blots
of whole cell lysate (Figure 8A). Nkx6-1 has, like Nkx2-2,
been shown to interact with Tle4 in in vitro binding assays
[8]. Nkx6-1 is critical for proper β-cell development and is
known to act generally as a transcriptional repressor [5].
We therefore wanted to determine if Tle2 could interact
with Nkx6-1. Anti-Tle2 blots of material immunoprecipi-
tated using an anti-Tle2 antibody produced an ~44 kDa
band that was not seen in controls but was found in west-
ern blots of whole cell lysate (Figure 8B). Interestingly, the
expected 46 kDa Nkx6-1 band could only be detected in
the western blot [39]. Next, we attempted to determine if
Tle2 interacts with Hes1, a critical mediator of Notch sig-
naling in pancreas development [40], which controls pan-
creas progenitor maintenance and specification [41-43].
Anti-Tle2 blots of material immunoprecipitated using an
anti-Hes1 antibody produced an ~83 kDa band (Figure
8C). Recently Arx was shown to have the ability to convert
both mature and developing β-cells into cells with an β-
cell phenotype [44]. Since it interacts with Tle1 [45] we
attempted to determine if it also interacts with Tle2. As Arx
is not normally expressed in β-cells we co-transfected a
6xHis tagged Arx expression vector with a Flag tagged Tle2
expression vector. Anti-His blots of material immunopre-
Relative expression of Gro/TLE family members in the developing pancreas and adult islets Figure 2
Relative expression of Gro/TLE family members in the developing pancreas and adult islets. Expression of Tle1, 
Tle2, Tle3, Tle4, Tle5 and Tle6 was assessed by qRT-PCR in E11.5 (used as reference), E13.5, E15.5, and E18.5 whole pancreases, 
as well as adult islets. The data shown is an average of the results obtained from pancreases from four separate litters (pancre-
ases from an individual litter were pooled), each with duplicate reactions or from four separate islet extractions. Error bars 
indicate the standard deviation of the three averaged replicates.
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cipitated using an anti-Tle2 antibody produced an ~63
kDa band that was not seen in controls but was found in
western blots of whole cell lysate (Figure 8D). In sum
these results indicate that Tle2 can interact with Nkx2-2,
Nkx6-1, Hes1, and Arx.
Expression of Tle1, Tle2, Tle3 and Tle4, as compared to Pdx1 expression, in the E12.5 pancreas Figure 3
Expression of Tle1, Tle2, Tle3 and Tle4, as compared to Pdx1 expression, in the E12.5 pancreas. Transverse sec-
tions of E12.5 pancreases were analyzed for the expression of (A) Tle1, (D) Tle2, (G) Tle3 or (J) Tle4 (green) in relation to 
(B, E, H, K) Pdx1 expression (red). Merged images are shown in (C, F, I L). Blue arrows indicate cells that are Gro/TLE + 
but not Pdx1+. Sections were photographed at ×200.
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Since Arx is able to convert mature β-cells into cells with
an α-cell phenotype, we hypothesized that Gro/TLE-Arx
interactions might be important to this ability. To assess
this possibility we used a rat insulin promoter (RIP)
reporter driving the expression of Enhanced Green Fluo-
rescent Protein (EGFP). Transfection of the RIP-EGFP
reporter with a Tle2 expression vector modestly reduced
the green fluorescence intensity (Figure 9). However,
transfection of the RIP-EGFP reporter with an Arx expres-
sion vector resulted in a 43% (p < 0.001) reduction in the
mean green fluorescence intensity produced by the
reporter as compared to transfection with the empty vec-
tor. Co-transfection of Arx with Tle2 resulted in a 61% (p
< 0.001) reduction in the mean green fluorescent intensity
produced by the reporter as compared to transfection with
empty vector, a significant reduction from transfection
with Arx alone (p < 0.01). Transfection with a Δeh1 Arx
construct, which lacks the Gro/TLE interaction domain,
resulted in a modest repression of the mean green fluores-
cence and co-transfection of this vector with the Tle2 vec-
tor did not alter the level of repression seen.
Discussion
Our qRT-PCR and IHC data indicate that the Gro/TLE pro-
teins are expressed throughout pancreas development and
suggest that they may act at multiple stages of pancreas
development. Interestingly, we see the expression of all
four Gro/TLE factors in the pancreatic mesenchyme. In
our GenePaint analysis we identified two transcription fac-
tors with a Gro/TLE interaction domain expressed in the
mesenchyme,  Nkx2-3  and  Tcf4. Tcf4 can interact with
Gro/TLE proteins [23] although the significance of these,
and any interactions between Nkx2-3 and Gro/TLE pro-
teins, in the pancreatic mesenchyme remains to be eluci-
dated. Tle1, 2, and 3 were expressed throughout the
epithelium in the pancreas prior to the secondary transi-
tion, while at E18.5 only Tle2 and Tle3 were broadly
expressed in the various developing endocrine cell types.
We identified 13 different transcription factors also
expressed in the endocrine lineage that contain Gro/TLE
interaction domains. Many of these factors have known
roles in pancreas development including Hes1  that is
essential for proper endocrine specification, as well as
Foxa2, Nkx2-2, Nkx6-1, and Pou3f4 (Arx) that are essential
for proper endocrine cell maturation. The presence of
these putative interacting transcription factors that are
essential to various steps of pancreas development in our
SAGE libraries further supports our hypothesis that the
Gro/TLE proteins play a role during multiple phases of
pancreas development.
At the initiation of pancreas development (~E8.5) pancre-
atic epithelial precursor cells express Pdx1, although scat-
tered Pdx1 negative Glucagon positive cells can be found.
The co-expression of Tle1, 2 and 3 at E12.5 agrees with
previous studies indicating that Gro/TLE expression over-
laps in progenitor cell populations in other tissues. Dur-
ing neuronal development it has been suggested the
primary role of the Gro/TLE factors is to maintain cells in
the progenitor state through interactions with Hes1 [46],
and they likely play this same role in the pancreas at this
time.
The differentiation of pancreatic progenitors into the var-
ious endocrine precursor cell types is under the control of
Notch signaling, via lateral inhibition [47]. During this
phase of pancreas development (E12.5–E14.5), called the
secondary transition, committed endocrine progenitor
cells are defined by their expression of Neurogenin 3
(Ngn3) [38] whose expression is otherwise repressed by
Hes1 [47]. At this time point we identified Ngn3 negative
Tle2/3 positive cells that likely represent duct cell precur-
sors generated from pancreatic progenitors in which active
Notch signaling has repressed Ngn3 activation. In addi-
tion, we find Ngn3 Tle2/3 double positive cells that
showed generally dim Ngn3 staining, suggestive of precur-
sors in which an endocrine fate has yet to be fully estab-
lished. Last we find Ngn3 bright cells that are Tle2/3
negative and likely represent committed endocrine pre-
cursors. As Tle1 and Tle4 are not expressed in the epithe-
lium at this time, these cells represent cells in which none
of the traditional Gro/TLE co-repressor factors are present,
indicating that the belief that these factors are ubiquitous
throughout pancreas development is incorrect. Regard-
less, the wide expression of Tle1, 2, and 3 prior to the sec-
ondary transition, and the obvious disappearance of Tle2
and Tle3 with concomitant appearance of Ngn3, suggests
that these factors play a role in Notch mediated lateral
inhibition. Our demonstration that Tle2 can interact with
Hes1 in pancreas cells, as it does in neural development
[27], provides additional support for this hypothesis.
By E18.5 Tle2 and Tle3 expression are clearly reactivated
and both were expressed broadly in endocrine cell types,
in agreement with our qRT-PCR data. Our E18.5 co-local-
Table 3: Summary of co-localization results of Tle1, 2, 3, and 4 
with Pdx1 on E12.5 embryonic pancreas tissue
Pdx1+ Pdx1- Mesenchyme
Tle1+ Yo No Y
Tle2+ Y Y Y
Tle3+ Y Y Y
Tle4+ N N Y
Tle1- N Y Y
Tle2- N N Y
Tle3- N N Y
Tle4- Y N Y
oY implies the indicated cell type was found, N indicates the cell type 
was not foundBMC Developmental Biology 2008, 8:81 http://www.biomedcentral.com/1471-213X/8/81
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Expression of Tle1, Tle2, Tle3 and Tle4, as compared to Ngn3 expression, in the E14.5 pancreas Figure 4
Expression of Tle1, Tle2, Tle3 and Tle4, as compared to Ngn3 expression, in the E14.5 pancreas. Transverse sec-
tions of E14.5 pancreases were analyzed for the expression of (A) Tle1, (D) Tle2, (G) Tle3 or (J) Tle4 (green) in relation to 
(B, E, H, K) Ngn3 expression (red). Merged images are shown in (C, F, I L). Blue arrows indicate cells that are Gro/TLE + 
but not Ngn3+. Yellow arrows indicate cells where the Gro/TLE proteins and Ngn3 co-localize. Green arrows indicate cells 
expressing Ngn3 only. Sections were photographed at ×200.
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ization data showed that Tle1 is expressed in Pdx1 (that
marks β and δ cells), Nkx2-2 (that marks α, β, and PP
cells), PP, and Somatostatin positive cells, but not in Insu-
lin or Glucagon positive cells suggesting that it is
expressed in δ and PP cell types, but not in α or β cells.
Tle2 co-localized with all the markers tested, indicating
that is expressed in α, β, δ and PP cell types. Tle3 co-local-
ized with all of the markers tested with the exception of
PP, and in agreement with this, Nkx2-2 positive Tle3 neg-
ative cells were found, indicating that Tle3 is expressed in
α, β, and δ cell types but not in PP cells. Tle4 was the least
abundant of the four Gro/TLE family members assessed
and co-localized with none of the markers tested suggest-
ing Tle4 may be expressed specifically in ghrelin produc-
ing ε cells, although this remains to be confirmed.
The obvious co-expression of the Gro/TLE proteins in islet
cells, as was found in pancreatic progenitors at E12.5, is
intriguing. Also of interest is the presence of rare Gro/TLE
negative, Insulin positive cells. Gro/TLE proteins have
been implicated in controlling the cell cycle [48] and we
show that some of these Gro/TLE negative cells represent
replicating β-cells. The expression and roles of these fac-
tors in ductal and acinar cells is also of interest. It is clear
that more work needs to be done to further assess the roles
of these factors in these cell types.
In general our IHC data agree with the relative expression
levels identified by qRT-PCR. In the qRT-PCR data, expres-
sion of Tle1 and 2 increased with development. At first
glance this may seem in disagreement with the IHC data
that indicates these factors decrease in expression in the
epithelium. However, it is worth noting that they are still
widely expressed in the surrounding mesenchyme. Tle3,
on the other hand, was not expressed widely in the mes-
enchyme and its expression clearly does drop at E13.5 to
E15.5 and is then reactivated at E18.5, as was found in the
Table 4: Summary of co-localization results of Tle1, 2, 3, and 4 
with Ngn3 on E14.5 embryonic pancreas tissue
Ngn3+ Ngn3- Mesenchyme
Tle1+ No NY o
Tle2+ Y Y Y
Tle3+ Y Y Y
Tle4+ N N Y
Tle1- Y Y Y
Tle2- Y Y Y
Tle3- Y Y Y
Tle4- Y Y Y
oY implies the indicated cell type was found, N indicates the cell type 
was not found
Close-up of the expression of Tle2 and Tle3, as compared to Ngn3 expression, in the E14.5 pancreas Figure 5
Close-up of the expression of Tle2 and Tle3, as compared to Ngn3 expression, in the E14.5 pancreas. Transverse 
sections of E14.5 pancreases were analyzed for the expression of (A) Tle2 or (D) Tle3 (green) in relation to (B, E) Ngn3 
expression (red). Merged images are shown in (C, F). Blue arrows indicate cells that are Gro/TLE + but not Ngn3+. Yellow 
arrows indicate cells where the Gro/TLE proteins and Ngn3 co-localize. Green arrows indicate cells expressing Ngn3 only. 
Sections are shown at ×400.
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Expression of Tle1, Tle2, Tle3 and Tle4, in relation to Pdx1, Nkx2-2, Insulin, Glucagon, Pancreatic polypeptide (PP), and Soma- tostatin expression, in the E18.5 pancreas Figure 6
Expression of Tle1, Tle2, Tle3 and Tle4, in relation to Pdx1, Nkx2-2, Insulin, Glucagon, Pancreatic polypeptide 
(PP), and Somatostatin expression, in the E18.5 pancreas. Saggital sections of E18.5 pancreases were analyzed for the 
expression of (A, E, I, M, Q, U) Tle1, (B, F, J, N, R, V) Tle2, (C, G, K, O, S, W) Tle3 or (D, H, L, P, T, X) Tle4 (green) 
in relation to (A, B, C, D) Pdx1, (E, F, G, H) Nkx2-2, (I, J, K, L) Insulin, (M, N, O, P) Glucagon, (Q, R, S, T) PP, or (U, 
V, W, X) Somatostatin expression (red). Blue arrows indicate cells that are Gro/TLE + but without co-localization, while yel-
low arrows indicate cells where the Gro/TLE proteins co-localize with Pdx1, Nkx2-2, Insulin, Glucagon, PP, or Somatostatin as 
appropriate, and green arrows indicate cells that express Pdx1, Nkx2-2, Insulin, Glucagon, PP, or Somatostatin, as appropriate, 
in the absence of Gro/TLE protein. Sections were photographed at ×200.
Tle1 Tle2 Tle3 Tle4
P
d
x
1
N
k
x
2
-
2
I
n
s
u
l
i
n
G
l
u
c
a
g
o
n
P
P
S
o
m
a
t
o
s
t
a
t
i
n
Tle1
Tle1
Tle1
Tle1
Tle1
Tle2
Tle2
Tle2
Tle2
Tle2
Tle3
Tle3
Tle3
Tle3
Tle3
Tle4
Tle4
Tle4
Tle4
Tle4
Tle1 Tle2 Tle3 Tle4
SS SS SS SS
Pdx1 Pdx1 Pdx1
Nkx2-2 Nkx2-2 Nkx2-2 Nkx2-2
Insulin Insulin
ABC D
E F G H
I J K L
M N O P
Q R S T
U V W X
Glucagon Glucagon Glucagon Glucagon
PP PP PP PP
Insulin Insulin
Pdx1BMC Developmental Biology 2008, 8:81 http://www.biomedcentral.com/1471-213X/8/81
Page 14 of 20
(page number not for citation purposes)
IHC data. Expression of all four of the Gro/TLE family
members analyzed here was relatively high in the adult
islets, again in agreement with the IHC data. Interestingly,
the qRT-PCR expression profiles of Tle1-Tle4 are quite dif-
ferent from that of Tle5  and  6. Additionally from our
GenePaint  analysis Tle5 and Tle6 are both abundantly
expressed throughout the pancreatic epithelium at E14.5.
It is striking to note that these data suggest that Tle1, 2,
and 3 are being shut off in Ngn3 positive endocrine pre-
cursors at roughly this time point. Tle5 is a dominant neg-
ative repressor of Tle1-Tle4 [9-12]. Likewise in neuronal
development Tle6 (Grg6) antagonizes Tle1 interactions
with BF-1 inhibiting BF-1 target gene repression and
inducing neural progenitors to differentiate [49]. It is
therefore likely these factors are acting to limit or prevent
Gro/TLE mediated target repression during pancreas
development and our expression data suggests this may
play an important role during the secondary transition.
Arx can repress Pax4 [4,50] and likely other β-cell specifi-
cation genes and convert β-cells and β-cell progenitors
into cells with an α-cell phenotype [44]. As this effect
includes the loss of insulin expression we used a rat pro-
moter insulin reporter construct to determine if Arx medi-
ated repression of β-cell transcripts is Gro/TLE dependent.
We found that co-expression of Arx and Tle2 enhanced
repression of the insulin reporter as compared to Arx
alone. However, this repression was not seen using an Arx
construct lacking the eh1 domain. These data suggest that
the repression of β-cell transcripts by Arx, which in turn
leads to the repression of insulin and other genes charac-
teristic of β-cells, is at least in part Gro/TLE dependent.
Our results agree with studies on neuronal development
that have defined a dual role for Gro/TLE factors in first
controlling the differentiation of progenitor cell types and
then later in the specification and maturation of specific
cell types [46]. Our co-immunoprecipitation data demon-
strates that Tle2 is able to interact with Nkx2-2, Nkx6-1,
Hes1 and Arx, which are key controllers of endocrine cell
specification and maturation. Further our IHC data indi-
cates that Tle2 and Tle3, in particular, co-localize with
these factors in pancreas development suggesting these
interactions occur in vivo. Based on our results we propose
a model for Gro/TLE action in the developing pancreas
(Figure 10). In this model Tle1, 2, and 3 initially play a
redundant role in enacting the repression of Hes1 target
genes, such as Ngn3, thereby maintaining the cells in a
progenitor state. In cells that begin to express higher Ngn3
levels, Hes1 expression is lost and cells differentiate into
multipotent endocrine progenitors. Subsequently tripo-
tent α/β/ε precursors develop into an ε (ghrelin produc-
ing) precursor or an α/β bipotent precursor based on
repression of the ε cell fate by Nkx2-2 [3]. Experimental
evidence has demonstrated that Gro/TLE interactions are
critical to this process and both Tle2 and 3 are co-
expressed with Nkx2-2 and can interact with it [3]. Subse-
quently, α/β-cell precursors undergo α or β cell specifica-
tion wherein we hypothesize that pro-β-cell eh1 motif
containing factors repress α-cell activating factors while
pro-α-cell eh1 motif containing factors repress α-cell acti-
vating factors, several of which do so in a putatively Gro/
TLE dependent fashion. The specific targets of these genes,
in general, are not known.
This model is, in part, based on the action of many of
these same pancreas-essential transcription factors in neu-
ronal development in which the interactions of cross
repressive transcription factors and Gro/TLE proteins are
critical for the proper inhibition of opposing factors [7,8].
Evidence suggesting that this model applies to pancreas
development is beginning to emerge. For example, Nkx2-
2 knock-out mice develop normal numbers of endocrine
precursors which differentiate almost exclusively into
ghrelin cells. Knock-in of a mutant Nkx2-2 composed of a
DNA binding domain and a Gro/TLE interaction domain,
but lacking an activation domain results in the develop-
ment of primarily α-cells [3]. In contrast knocking in a
mutant Nkx2-2 containing the activation domain but not
the Gro/TLE interaction domain produces a phenotype
similar to the Nkx2-2 knock out. These data suggest that
repression of pro-ghrelin cell factors via Gro/TLE proteins
Table 5: Summary of co-localization results of Tle1, 2, 3, and 4 with Pdx1, Nkx2.2, Insulin, Glucagon, Pancreatic polypeptide (PP), and 
Somatostatin (SS) on E18.5 embryonic pancreas tissue
Pdx1+ Pdx1- Nkx2-2+ Nkx2-2- Ins+ Ins- Glu+ Glu- PP+ PP- SS+ SS-
Tle1+ Yo YY Y N o YN YY Y Y Y
Tle2+ Y Y Y Y Y Y Y Y Y Y Y Y
Tle3+ Y Y Y Y Y Y Y Y N Y Y Y
Tle4+ N Y N Y N Y N Y N Y N Y
Tle1- Y Y Y Y Y Y Y Y Y Y Y Y
Tle2- N Y N Y N Y N Y N Y N Y
Tle3- N Y Y Y N Y Y Y Y Y Y Y
Tle4- Y Y Y Y Y Y Y Y Y Y Y Y
oY implies the indicated cell type was found, N indicates the cell type was not foundBMC Developmental Biology 2008, 8:81 http://www.biomedcentral.com/1471-213X/8/81
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Expression of Tle1, Tle2, Tle3 and Tle4, in relation to insulin and glucagon expression, in the adult pancreas Figure 7
Expression of Tle1, Tle2, Tle3 and Tle4, in relation to insulin and glucagon expression, in the adult pancreas. 
Saggital sections of adult pancreases were analyzed for the expression of (A, B) Tle1, (C, D) Tle2, (E, F) Tle3 or (G, H) Tle4 
(green) in relation to (A, C, E, G) insulin or (B, D, F, H) glucagon expression (red). Merged images are shown at 200× and 
images highlighting regions containing cells that are insulin or glucagon positive but Gro/TLE negative are shown both merged 
and with the channels separated at 400x. In (I) staining with a pan-TLE antibody in relationship to (J) PCNA is shown, (K) 
Hoescht staining shows the location of nuclei, and (L) shows the merged image. Blue arrows indicate cells that are Gro/TLE + 
but not insulin+ or glucagon +, while yellow arrows indicate cells where the Gro/TLE proteins and insulin or glucagon co-local-
ize, and green arrows indicate cells that express insulin or glucagon only. Sections were photographed at ×200.
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is essential for the appropriate differentiation of a hypo-
thetical tripotent (α, β, and ghrelin cell) precursor into a
bipotent α/β cell precursor; whereas activation of target
genes by Nkx2-2 is required for the proper differentiation
of α/β progenitors into β-cells. In addition, Nkx6-1 and
Nkx6-2 act in a cross repressive fashion during motor neu-
ron development [7,30,51] and at least in the case of
Nkx6-1 this repression is Gro/TLE dependent [8]. The
expression of Nkx6-2 in the pancreas can be seen from
E8.5 to E10.5 whereas Nkx6-1 becomes predominantly
expressed starting at E11.5 [36] and Nkx6-1 knock-out
mice have elevated levels of Nkx6-2 [52]. These data sug-
gest that Nkx6-1 represses Nkx6-2 in a Gro/TLE dependent
manner as occurs in motor neuron development [30].
Recent evidence indicates Nkx6-1 does not act to repress
alternative cell fates directly [36] and instead acts to
"prime" progenitor cells to be able to become β-cells.
How the repressive versus activational activities of Nkx6-
1 factor into this remains to be elucidated, although it
seems likely that Nkx6-1 inhibits the expression of factors
that repress pro-β cell factors such as Myt1, whose expres-
Table 6: Summary of co-localization results of Tle1, 2, 3, and 4 
with Insulin, Glucagon and DBA on adult pancreas tissue
Ins+ Ins- Glu+ Glu- Ductal (DBA+) Acinar
Tle1+ Yo YYY N o Y
Tle2+ Y Y Y Y Y Y
Tle3+ Y Y Y Y Y Y
Tle4+ Y Y Y Y N Y
Tle1- Y Y Y Y Y Y
Tle2- Y Y N Y N Y
Tle3- Y Y N Y N Y
Tle4- Y Y Y Y Y Y
oY implies the indicated cell type was found, N indicates the cell type 
was not found
Interaction of Tle2 with selected factors Figure 8
Interaction of Tle2 with selected factors. Immunopre-
cipitations were performed by incubating 200 ug of Min6 cel-
lular lysate with antibodies against Tle2 (+) or IgG (-). Lysate 
lanes containing whole cell extracts were included as a west-
ern blot control. Blots were probed with antibodies against 
endogenously expressed (A) Nkx2-2 or (B) Nkx6-1. (C) 
Immunoprecipitations using antibodies against Hes1 (+) or 
IgG (-) with subsequent blotting with antibodies against Tle2. 
This was done since the Hes1 band was obscured by the IgG 
heavy chain band in anti-Tle2 immunoprecpitations with sub-
sequent anti-Hes1 blotting. In (D) an Arx cDNA containing a 
C-terminal 6xHis tag was transiently transfected into Min6 
cells, due to the lack of endogenous Arx expression in these 
cells, 48 hrs prior to the IP and the resulting immunoprecip-
tate probed with an anti-6xHis antibody.
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Tle2 enables Arx mediated insulin reporter suppression Figure 9
Tle2 enables Arx mediated insulin reporter suppres-
sion. Min6 cells were transfected with a Rat Insulin Pro-
moter (RIP) EGFP reporter and with either pCMS-HA (HA) 
vector, pCMS-Flag-Tle2 (Tle2), pCMS-Arx (Arx), pCMS-Flag-
Tle2 and pCMS-Arx (Tle2/Arx), pCMS-Arx Δeh1 (Arx 
Δeh1), or pCMS-Flag-Tle2 and pCMS-Arx Δeh1 (Tle2/Arx 
Δeh1). The average of four independent experiments is 
shown in (A) and representative histograms from one 
experiment in (B). Statistical analysis was carried out using a 
one way ANOVA with a Bonferroni Multiple Comparison 
post test to compare means. * p < 0.01 and ** p < 0.001 (n = 
4 experiments with triplicate samples in each experiment).
200
A
HA
Tle2
Arx
Tle2/Arx
Arx Δeh1
Tle2/Arx Δeh1
800
600
400
0
M
e
a
n
 
G
r
e
e
n
 
F
l
o
u
r
e
s
c
e
n
c
e
pCMS-HA
pCMS-HA pCMS-HA
pCMS-Tle2
pCMS-Arx
pCMS-HA
pCMS-Tle2/
pCMS-Arx
pCMS-Arx Δeh1
pCMS-HA pCMS-HA
pCMS-Tle2/
pCMS-Arx Δeh1
80
20
40
60
0
80
20
40
60
0
80
20
40
60
0
80
20
40
60
0
80
20
40
60
0
80
20
40
60
0
0 10
1 10
3 10
4 10
2 0 10
1 10
3 10
4 10
2
0 10
1 10
3 10
4 10
2 0 10
1 10
3 10
4 10
2
0 10
1 10
3 10
4 10
2 0 10
1 10
3 10
4 10
2
**
**
*
Fl1- Green Flourescence Fl1- Green Flourescence
Fl1- Green Flourescence Fl1- Green Flourescence
Fl1- Green Flourescence Fl1- Green Flourescence
BBMC Developmental Biology 2008, 8:81 http://www.biomedcentral.com/1471-213X/8/81
Page 17 of 20
(page number not for citation purposes)
sion is reduced in Nkx6-1-/- mice [52]. On the other hand,
Arx misexpression throughout the developing pancreas
induces a clear loss of β and δ cells [44]. In fact, Arx is
directly cross-repressive with Pax4 during pancreas devel-
opment [4], further indicating that this factor represses
genes essential to alternative cell fates and here we show
that Arx interacts with Tle2 and that Tle2 modulates it's
repressive effects.
Conclusion
At least 13 Gro/TLE interaction domain containing tran-
scription factors are expressed in the endocrine pancreas
lineage. These factors are known to control multiple criti-
cal steps in pancreatic development including progenitor
cell specification as well as endocrine cell type specifica-
tion and maturation. Tle1, 2, 3, and 4 are expressed
dynamically during pancreas development. Tle1, 2, and 3
overlap in expression in the pancreatic epithelium at
E12.5 suggesting they have redundant roles at this time.
During the secondary transition their expression alters
dramatically with Tle1 being lost from the epithelium and
Tle2 and Tle3 expressed in only a subset of Ngn3 positive
cells. This indicates that as Ngn3 expressing cells mature
they lose Tle2 and Tle3 expression. However, by E18.5
these factors are re-activated and co-expressed in α, β, and
δ cells, although only Tle2 was found in PP cells. Tle1
expressing cells were less abundant and we show Tle1 is
expressed in δ and PP cells but not in α or β cells. Tle4 was
only found in a rare subset of endocrine cells that did not
express any of the markers tested. We also show that Tle2
can interact with factors involved in progenitor cell main-
tenance (Hes1), and endocrine cell maturation and speci-
fication (Nkx2-2, Nkx6-1, and Arx). Moreover, we provide
evidence that Tle2 modulates the ability of Arx to repress
the β-cell phenotype using a rat insulin reporter in a Gro/
TLE interaction domain dependent fashion. In sum these
data suggest that Tle1 – 4 are involved in a wide range of
processes and are recruited by numerous transcription fac-
tors essential to proper pancreas development and func-
tion.
Methods
Mouse maintenance and islet isolation
All mice were bred and maintained at the British Colum-
bia Cancer Research Centre animal facility according to
the guidelines of the Canadian Council on Animal Care.
All protocols were approved by the University of British
Columbia Animal Care Committee. Mice were housed in
microisolator units, provided with Purina mouse food
and autoclaved water ad libidum, and were maintained at
20°C ± 2°C under a light/dark cycle (light: 05:00–19:00
and dark: 19:00–05:00). Males were mated overnight with
up to three females and females were checked for plugs
before 9:30 the following morning. Plugged mice were
considered to be 0.5 days post coitum (dpc). Islets were
purified from 8–10 week old ICR males by collagenase
digestion and gradient centrifugation as previously
described [53].
SAGE data analysis
SAGE data was analyzed using DiscoverySpace4 [54]. All
SAGE libraries were generated and sequenced as part of
the Mouse Atlas of Gene Expression [31] and Mammalian
Organogenesis (MORGEN) projects. The data was filtered
for sequence quality so that each tag had a 95% or greater
probability of being correct, using the PHRED score qual-
ity assessment software [55]. Tag to gene mapping was
performed using the mouse Refseq, MGC, and Ensembl
databases using the DiscoverySpace program. Tags were
considered sense position matches if they mapped in the
sense orientation to the gene and antisense matches if
they mapped in the opposite orientation. A tag was con-
sidered unambiguous if it matched a single sense position
A model of the proposed role of the Gro/TLE factors in cell  fate choices during endocrine pancreas development Figure 10
A model of the proposed role of the Gro/TLE factors 
in cell fate choices during endocrine pancreas devel-
opment. A schematic depicting a cross-repressive model of 
the genetic network regulating α-, β-, and ε-cell fate is shown 
based on our experimental data, as well as evidence from the 
literature on pancreas development [3,47] and on models of 
neuronal cell specification.
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gene in all of the databases, and ambiguous if it mapped
to multiple genes in a sense position regardless of the
mapping position. The specificity of tags was determined
by first obtaining the counts for the tags in 205 different
Mouse Atlas Libraries. From this the mean of the tag
counts in all the libraries (Ma) was determined and com-
pared to tag count in the library of interest (Ci) to obtain
the mean ratio (Mr). The total number of libraries the tag
was found in, or library count, was next determined (La)
as was the total counts of the tag in the library under anal-
ysis (Ci). The specificity (S) was then calculated as: S = Mr
log1.3(Ci)/La. Thus tags with a high mean ratio that appear
in relatively few libraries and are expressed more abun-
dantly will have the highest specificities.
Quantitative real-time PCR
Probes for Tle1, 2, 3, and 4 as well as GAPDH were pur-
chased from Applied Biosystems, Foster City, CA. An ABI
7500 real-time PCR system (Applied Biosystems) and
Universal PCR Master Mix (Applied Biosystems) was used
for all reactions. Six replicate cDNAs were obtained by
reverse transcription (RT) of 1 μg of total RNA from newly
isolated embryonic pancreas tissue or from Min6 cells for
each RT. 10 ng of generated cDNA was used in each reac-
tion with all reactions done in duplicate. Samples were
normalized to Gapdh, and the fold increase compared to
E11.5 pancreas or untreated Min6 cells (as appropriate)
was calculated using 2-ΔΔCt [56].
GenePaint Analyses
Images of in situ hybridization staining patterns for whole
embryo sagittal sections were obtained from the GenePa-
int  website (Visel et al., http://www.GenePaint.org).
Higher magnification images of the area of the embryo
containing the pancreas were obtained and the pancreas
outlined. The brightness and contrast of some of the
images was altered using Photoshop to better assess the
staining pattern. Genes were then classified as showing
trunk, tip, epithelial, mesenchymal or vasculature staining
[57].
Immunohistochemistry
Immunohistochemistry was performed on E12.5, E14.5,
E18.5 embryonic, or adult, pancreas cryo-sections sec-
tions using the following antibodies: 1/100 dilution of
guinea pig anti-Insulin (Stem Cell Technologies Inc.); 1/
500 dilution of guinea pig anti-Glucagon (Linco); 1/100
dilution of guinea pig anti-PP (Millipore); 1/1000 dilu-
tion of mouse anti-Somatostatin (Santa Cruz); 1/100
dilution of mouse anti-Nkx2-2 (Developmental Studies
Hybridoma Bank); 1/100 dilution of mouse anti-Ngn3
(Developmental Studies Hybridoma Bank); 1/10,000
dilution of guinea pig anti-Pdx1 (kindly provided by
Christopher Wright); 1/1000 dilution of rabbit anti-Tle1
(kindly provided by Stefano Stifani); 1/1000 dilution of
rabbit anti-Tle2 (Santa Cruz); 1/1000 dilution of rabbit
anti-Tle3 (Santa Cruz); 1/1000 dilution of rabbit anti-Tle4
(kindly provided by Stefano Stifani); 1/100 dilution of
rabbit anti-pan TLE (Santa Cruz); 1/100 dilution of
mouse anti-PCNA. Primary antibodies were detected
using a 1/2000 dilution of Alexa 488 or Alexa 546 conju-
gated anti-rabbit, anti-mouse, anti-goat or anti-guinea pig
(Invitrogen) antibodies as appropriate.
Cell Culture and Co-Immunoprecipitation
Min6 cells were maintained in high glucose (4,500 mg/l)
Dulbecco's Modified Eagle's Medium (DMEM; StemCell
Technologies Inc.) supplemented with 10% fetal calf
serum and 5 mM L-glutamine. Immunoprecipitations
were performed on 3 × 106 Min6 cells or Min6 cells trans-
fected with pCMS-6xHis-Arx and pCMS-Flag-Tle2, as
appropriate. Cells were lysed and pre-cleared with 20 uL
ProteinA-Sepharose (Rockland) to reduce background.
Supernatants were incubated with 10 ug Rabbit Anti-Tle2
at 4° for 2 hours, and then with 20 uL of a 50% ProteinA-
Sepharose slurry for 1 hour. Beads were washed three
times in lysis buffer, resuspended in SDS sample buffer
and electrophoresed on a 10% poly-acrylamide gel. Pro-
teins pulled down using an anti-Tle2 (Santa Cruz) or anti-
Hes1 (Santa Cruz) antibody were immunoblotted onto
Immobilon-P membranes (Millipore) and detected with
mouse anti-Nkx2-2 (Developmental Studies Hybridoma
Bank), mouse anti-Nkx6-1 (Developmental Studies
Hybridoma Bank), rabbit anti-Tle2 (Santa Cruz), or rabbit
anti-His (Abcam). Negative controls to assess the specifity
of the pulldowns included: rabbit IgG pulldowns and
lysate only controls.
Rat Insulin Reporter Assays
Assays were performed by transfecting 2 × 105 Min6 cells
with 600 ng of the appropriate vectors using Lipo-
fectamine (Invitrogen) (pCMV-HA was used to adjust
total DNA amounts) using the following amounts as
appropriate: 300 ng of rat insulin promoter EGFP reporter
plasmid, 50 ng of pCMS-Arx, 50 ng of pCMS-Arx Δeh1,
200 ng of pCMS-Flag-Tle2. 48 hrs after transfection the
cells were harvested and single cell-suspensions prepared.
Cells were then stained with 7-AAD (5 μg/ml) and ana-
lyzed by flow cytometry using a FACSCalibur flow cytom-
eter and CELLQuest software (BD Pharmigen). Cells were
gated based on the forward- versus side-scatter profile and
on the 7-AAD versus forward scatter profiles to gate for
viable cells, and a pCMS-HA only transfected sample was
used to determine appropriate gating. The mean green flu-
orescence intensity was then determined for the samples
using the CELLQuest software (BD Pharmingen).
Authors' contributions
BH performed all IHC, SAGE data analysis, and GenePa-
int analysis; assisted with the qRT-PCR studies and RIPBMC Developmental Biology 2008, 8:81 http://www.biomedcentral.com/1471-213X/8/81
Page 19 of 20
(page number not for citation purposes)
assays, and wrote the manuscript. BZ performed co-
immunoprecipitation experiments and assisted with the
qRT-PCR studies. MB performed the Rat insulin promoter
assays. CH is the senior author. All authors have read and
approved the manuscript.
Acknowledgements
The authors would like to acknowledge the staff of the Animal Resource 
Center at the BBCRC. In addition we would like to thank Stefano Stifani 
(McGill University) for providing the anti-Tle1 and anti-Tle4 antibodies, as 
well as Chris Wright (Vanderbilt) for providing the anti-Pdx1 antibody. We 
also would like to thank James Piret (UBC) for providing us with the rat 
insulin promoter construct and Joy Witzsche for performing the cryosec-
tioning. Cheryl D. Helgason is a scholar of the Michael Smith Foundation 
for Health Research. Funding was provided by the Genome Canada con-
tracts "Mouse Atlas of Development" and "MORGEN", the National Insti-
tute of Health (USA), and StemCell Technologies Inc., with infrastructure 
support provided by the BC Cancer Foundation.
References
1. Wei Q, Miskimins WK, Miskimins R: Stage-specific expression of
myelin basic protein in oligodendrocytes involves NKX2.2-
mediated repression that is relieved by the Sp1 transcription
factor.  J Biol Chem 2005, 280(16):16284-16294.
2. Sun T, Echelard Y, Lu R, Yuk DI, Kaing S, Stiles CD, Rowitch DH: Olig
bHLH proteins interact with homeodomain proteins to reg-
ulate cell fate acquisition in progenitors of the ventral neural
tube.  Curr Biol 2001, 11:1413-1420.
3. Doyle MJ, Loomis ZL, Sussel L: Nkx2.2-repressor activity is suffi-
cient to specify {alpha}-cells and a small number of {beta}-
cells in the pancreatic islet.  Development 2007, 134:515-523.
4. Collombat P, Hecksher-Sorensen J, Broccoli V, Krull J, Ponte I, Mun-
diger T, Smith J, Gruss P, Serup P, Mansouri A: The simultaneous
loss of Arx and Pax4 genes promotes a somatostatin-pro-
ducing cell fate specification at the expense of the alpha- and
beta-cell lineages in the mouse endocrine pancreas.  Develop-
ment 2005, 132:2969-2980.
5. Iype T, Taylor DG, Ziesmann SM, Garmey JC, Watada H, Mirmira RG:
The transcriptional repressor Nkx6.1 also functions as a
deoxyribonucleic acid context-dependent transcriptional
activator during pancreatic beta-cell differentiation: evi-
dence for feedback activation of the nkx6.1 gene by Nkx6.1.
Mol Endocrinol 2004, 18:1363-1375.
6. Mirmira RG, Watada H, German MS: Beta-cell differentiation fac-
tor Nkx6.1 contains distinct DNA binding interference and
transcriptional repression domains.  J Biol Chem 2000,
275:14743-14751.
7. Lee SK, Pfaff SL: Transcriptional networks regulating neuronal
identity in the developing spinal cord.  Nat Neurosci 2001,
4(Suppl):1183-1191.
8. Muhr J, Andersson E, Persson M, Jessell TM, Ericson J: Groucho-
mediated transcriptional repression establishes progenitor
cell pattern and neuronal fate in the ventral neural tube.  Cell
2001, 104:861-873.
9. Chen G, Courey AJ: Groucho/TLE family proteins and tran-
scriptional repression.  Gene 2000, 249:1-16.
10. Jimenez G, Paroush Z, Ish-Horowicz D: Groucho acts as a core-
pressor for a subset of negative regulators, including Hairy
and Engrailed.  Genes Dev 1997, 11:3072-3082.
11. Gasperowicz M, Otto F: Mammalian Groucho homologs:
redundancy or specificity?  J Cell Biochem 2005, 95:670-687.
12. Palaparti A, Baratz A, Stifani S: The Groucho/transducin-like
enhancer of split transcriptional repressors interact with the
genetically defined amino-terminal silencing domain of his-
tone H3.  J Biol Chem 1997, 272:26604-26610.
13. Dehni G, Liu Y, Husain J, Stifani S: TLE expression correlates with
mouse embryonic segmentation, neurogenesis, and epithe-
lial determination.  Mech Dev 1995, 53:369-381.
14. Yao J, Liu Y, Husain J, Lo R, Palaparti A, Henderson J, Stifani S: Com-
binatorial expression patterns of individual TLE proteins
during cell determination and differentiation suggest non-
redundant functions for mammalian homologs of Drosophila
Groucho.  Dev Growth Differ 1998, 40:133-146.
15. Allen T, Lobe CG: A comparison of Notch, Hes and Grg
expression during murine embryonic and post-natal devel-
opment.  Cell Mol Biol (Noisy-le-grand) 1999, 45:687-708.
16. Brinkmeier ML, Potok MA, Cha KB, Gridley T, Stifani S, Meeldijk J,
Clevers H, Camper SA: TCF and Groucho-related genes influ-
ence pituitary growth and development.  Mol Endocrinol 2003,
17:2152-2161.
17. Cai Y, Brophy PD, Levitan I, Stifani S, Dressler GR: Groucho sup-
presses Pax2 transactivation by inhibition of JNK-mediated
phosphorylation.  Embo J 2003, 22:5522-5529.
18. Nutt SL, Eberhard D, Horcher M, Rolink AG, Busslinger M: Pax5
determines the identity of B cells from the beginning to the
end of B-lymphopoiesis.  Int Rev Immunol 2001, 20:65-82.
19. Wang WF, Wang YG, Reginato AM, Plotkina S, Gridley T, Olsen BR:
Growth defect in Grg5 null mice is associated with reduced
Ihh signaling in growth plates.  Dev Dyn 2002, 224:79-89.
20. Bajoghli B, Aghaallaei N, Czerny T: Groucho corepressor pro-
teins regulate otic vesicle outgrowth.  Dev Dyn 2005,
233:760-771.
21. Lopez-Rios J, Tessmar K, Loosli F, Wittbrodt J, Bovolenta P: Six3 and
Six6 activity is modulated by members of the groucho fam-
ily.  Development 2003, 130:185-195.
22. Kobayashi M, Nishikawa K, Suzuki T, Yamamoto M: The homeobox
protein Six3 interacts with the Groucho corepressor and
acts as a transcriptional repressor in eye and forebrain for-
mation.  Dev Biol 2001, 232:315-326.
23. Brantjes H, Roose J, Wetering M van De, Clevers H: All Tcf HMG
box transcription factors interact with Groucho-related co-
repressors.  Nucleic Acids Res 2001, 29:1410-1419.
24. Wang JC, Waltner-Law M, Yamada K, Osawa H, Stifani S, Granner
DK: Transducin-like enhancer of split proteins, the human
homologs of Drosophila groucho, interact with hepatic
nuclear factor 3beta.  J Biol Chem 2000, 275:18418-18423.
25. Nuthall HN, Husain J, McLarren KW, Stifani S: Role for Hes1-
induced phosphorylation in Groucho-mediated transcrip-
tional repression.  Mol Cell Biol 2002, 22:389-399.
26. McLarren KW, Theriault FM, Stifani S: Association with the
nuclear matrix and interaction with Groucho and RUNX
proteins regulate the transcription repression activity of the
basic helix loop helix factor Hes1.  J Biol Chem 2001,
276:1578-1584.
27. Grbavec D, Lo R, Liu Y, Stifani S: Transducin-like Enhancer of
split 2, a mammalian homologue of Drosophila Groucho,
acts as a transcriptional repressor, interacts with Hairy/
Enhancer of split proteins, and is expressed during neuronal
development.  Eur J Biochem 1998, 258:339-349.
28. Yao J, Lai E, Stifani S: The winged-helix protein brain factor 1
interacts with groucho and hes proteins to repress transcrip-
tion.  Mol Cell Biol 2001, 21:1962-1972.
29. Sander M, Paydar S, Ericson J, Briscoe J, Berber E, German M, Jessell
TM, Rubenstein JL: Ventral neural patterning by Nkx home-
obox genes: Nkx6.1 controls somatic motor neuron and ven-
tral interneuron fates.  Genes Dev 2000, 14:2134-2139.
30. Vallstedt A, Muhr J, Pattyn A, Pierani A, Mendelsohn M, Sander M, Jes-
sell TM, Ericson J: Different levels of repressor activity assign
redundant and specific roles to Nkx6 genes in motor neuron
and interneuron specification.  Neuron 2001, 31:743-755.
31. Siddiqui AS, Khattra J, Delaney AD, Zhao Y, Astell C, Asano J,
Babakaiff R, Barber S, Beland J, Bohacec S, Brown-John M, Chand S,
Charest D, Charters AM, Cullum R, Dhalla N, Featherstone R, Ger-
hard DS, Hoffman B, Holt RA, Hou J, Kuo BY, Lee LL, Lee S, Leung D,
Ma K, Matsuo C, Mayo M, McDonald H, Prabhu AL, et al.: A mouse
atlas of gene expression: large-scale digital gene-expression
profiles from precisely defined developing C57BL/6J mouse
tissues and cells.  Proc Natl Acad Sci USA 2005, 102:18485-18490.
32. Hoffman BG, Zavaglia B, Witzsche J, Ruiz de Algara T, Beach M,
Hoodless PA, Jones SJ, Marra MA, Helgason CD: Identification of
transcripts with enriched expression in the developing and
adult pancreas.  Genome Biol 2008, 9:R99.
33. Lammert E, Brown J, Melton DA: Notch gene expression during
pancreatic organogenesis.  Mech Dev 2000, 94:199-203.
34. Li H, Arber S, Jessell TM, Edlund H: Selective agenesis of the dor-
sal pancreas in mice lacking homeobox gene Hlxb9.  Nat Genet
1999, 23:67-70.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Developmental Biology 2008, 8:81 http://www.biomedcentral.com/1471-213X/8/81
Page 20 of 20
(page number not for citation purposes)
35. Sander M, Sussel L, Conners J, Scheel D, Kalamaras J, Dela Cruz F,
Schwitzgebel V, Hayes-Jordan A, German M: Homeobox gene
Nkx6.1 lies downstream of Nkx2.2 in the major pathway of
beta-cell formation in the pancreas.  Development 2000,
127:5533-5540.
36. Nelson SB, Schaffer AE, Sander M: The transcription factors
Nkx6.1 and Nkx6.2 possess equivalent activities in promot-
ing beta-cell fate specification in Pdx1+ pancreatic progeni-
tor cells.  Development 2007, 134:2491-2500.
37. McKinnon C, Docherty K: Pancreatic duodenal homeobox-1,
PDX-1, a major reulator of beta cell identity and function.
Diabetologia 2001, 44:1203-1214.
38. Gu G, Dubauskaite J, Melton D: Direct evidence for the pancre-
atic lineage: NGN3+ cells are islet progenitors and are dis-
tinct from duct progenitors.  Development 2002, 129:2447-2457.
39. Jensen J, Serup P, Karlsen C, Nielsen TF, Madsen OD: mRNA pro-
filing of rat islet tumors reveals nkx 6.1 as a beta-cell-specific
homeodomain transcription factor.  J Biol Chem 1996,
271:18749-18758.
40. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M,
Kageyama R, Guillemot F, Serup P, Madsen OD: Control of endo-
dermal endocrine development by Hes-1.  Nat Genet 2000,
24:36-44.
41. Jensen J, Heller RS, Funder-Nielsen T, Pedersen EE, Lindsell C, Wein-
master G, Madsen OD, Serup P: Independent development of
pancreatic alpha- and beta-cells from neurogenin3-express-
ing precursors: a role for the notch pathway in repression of
premature differentiation.  Diabetes 2000, 49:163-176.
42. Apelqvist A, Li H, Sommer L, Beatus P, Anderson D, Honjo T, Hrabe
de Angelis M, Lendahl U, Edlund H: Notch signalling controls pan-
creatic cell differentiation.  Nature 1999, 400:877-881.
43. Murtaugh LC, Stanger BZ, Kwan KM, Melton DA: Notch signaling
controls multiple steps of pancreatic differentiation.  Proc Natl
Acad Sci USA 2003, 100:14920-14925.
44. Collombat P, Hecksher-Sorensen J, Krull J, Berger J, Riedel D, Her-
rera PL, Serup P, Mansouri A: Embryonic endocrine pancreas
and mature beta cells acquire alpha and PP cell phenotypes
upon Arx misexpression.  J Clin Invest 2007, 117:961-970.
45. McKenzie O, Ponte I, Mangelsdorf M, Finnis M, Colasante G, Shou-
bridge C, Stifani S, Gecz J, Broccoli V: Aristaless-related home-
obox gene, the gene responsible for West syndrome and
related disorders, is a Groucho/transducin-like enhancer of
split dependent transcriptional repressor.  Neuroscience 2007,
146:236-247.
46. Yao J, Liu Y, Lo R, Tretjakoff I, Peterson A, Stifani S: Disrupted
development of the cerebral hemispheres in transgenic mice
expressing the mammalian Groucho homologue transducin-
like-enhancer of split 1 in postmitotic neurons.  Mech Dev
2000, 93:105-115.
47. Jensen J: Gene regulatory factors in pancreatic development.
Dev Dyn 2004, 229:176-200.
48. Nuthall HN, Joachim K, Palaparti A, Stifani S: A role for cell cycle-
regulated phosphorylation in Groucho-mediated transcrip-
tional repression.  J Biol Chem 2002, 277:51049-51057.
49. Marcal N, Patel H, Dong Z, Belanger-Jasmin S, Hoffman B, Helgason
CD, Dang J, Stifani S: Antagonistic effects of Grg6 and Groucho/
TLE on the transcription repression activity of brain factor
1/FoxG1 and cortical neuron differentiation.  Mol Cell Biol 2005,
25:10916-10929.
50. Collombat P, Mansouri A, Hecksher-Sorensen J, Serup P, Krull J,
Gradwohl G, Gruss P: Opposing actions of Arx and Pax4 in
endocrine pancreas development.  Genes Dev 2003,
17:2591-2603.
51. Pattyn A, Vallstedt A, Dias JM, Sander M, Ericson J: Complemen-
tary roles for Nkx6 and Nkx2 class proteins in the establish-
ment of motoneuron identity in the hindbrain.  Development
2003, 130:4149-4159.
52. Henseleit KD, Nelson SB, Kuhlbrodt K, Hennings JC, Ericson J, Sander
M: NKX6 transcription factor activity is required for alpha-
and beta-cell development in the pancreas.  Development 2005,
132:3139-3149.
53. Marzban L, Soukhatcheva G, Verchere CB: Role of carboxypepti-
dase E in processing of pro-islet amyloid polypeptide in
{beta}-cells.  Endocrinology 2005, 146:1808-1817.
54. Robertson N, Oveisi-Fordorei M, Zuyderduyn SD, Varhol RJ, Fjell C,
Marra M, Jones S, Siddiqui A: DiscoverySpace: an interactive
data analysis application.  Genome Biol 2007, 8:R6.
55. Ewing B, Green P: Base-calling of automated sequencer traces
using phred. II. Error probabilities.  Genome Res 1998,
8:186-194.
56. Pfaffl MW: A new mathematical model for relative quantifica-
tion in real-time RT-PCR.  Nucleic Acids Res 2001, 29:e45.
57. Zhou Q, Law AC, Rajagopal J, Anderson WJ, Gray PA, Melton DA: A
multipotent progenitor domain guides pancreatic organo-
genesis.  Dev Cell 2007, 13:103-114.